Skip to main content

Multiple Sclerosis

Editor's Choice

The immunomodulating drug teriflunomide reduces the risk for developing multiple sclerosis in patients with radiologically isolated syndrome.

Recent evidence of effectiveness and acceptable safety reinforces that autologous hematopoietic stem cell transplantation is a clinical option for aggressive relapsing–remitting multiple sclerosis.

An overview of the clinical manifestations and treatment of demyelinating and autoimmune optic neuritis, which is the most common cause of subacute optic neuropathy in young adults.

Current Reviews

Episode 5: Next-generation sequencing

Emerging biomarkers in thyroid and non-small cell lung cancers

Next-generation sequencing is a powerful tool that can identify mutations or fusions in a wide range of cancers, enabling physicians to provide targeted therapy to patients and improve outcomes. In this podcast, Professor Andrew Beggs discusses practical aspects of this technique from the clinical viewpoint.

This content is intended only for healthcare providers and was made possible by educational funding provided by Illumina, Inc., and Eli Lilly and Company.

Listen now

Case Studies

The first report of filgrastim being used to treat PML secondary to fingolimod in a patient with relapsing–remitting multiple sclerosis, resulting in a favourable response.

Biochemical hyperthyroidism in a patient with multiple sclerosis. Awareness of biotin use is key to avoiding misdiagnosis and inappropriate treatment as biotin can interfere with thyroid test results.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Further Reading